Evidence map›Paper›PMID 28092664›Full record

ArticleNature medicine2017

Expression of specific inflammasome gene modules stratifies older individuals into two extreme clinical and immunological states.

David Furman, Junlei Chang, Lydia Lartigue, Christopher R Bolen, François Haddad, Brice Gaudilliere, Edward A Ganio, Gabriela K Fragiadakis, Matthew H Spitzer, Isabelle Douchet and 10 more

2 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in Nature medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 237 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
237citing papers in PubMed, 3 pooled it
18.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01827462 phase4completednot on this map

Immune Senescence in the Elderly: Comparison of Immune Responses to Influenza Vaccine In Adults of Different Ages

TypeinterventionalSponsorStanford UniversityRan2007 to 2017Enrolled136ConditionsInfluenzaArmsTrivalent, inactivated influenza vaccine (TIV), Quadrivalent, inactivated influenza vaccine (IIV4), High-Dose Trivalent, inactivated influenza vaccine (TIV High-Dose)
NCT03191175 completednot on this map

Residual Immune Activation in HIV-infected Patients on Successful cART: Association Between Inflammasome Activation in Monocytes by Circulating Metabolites and Non AIDS Defining Comorbidities

TypeobservationalSponsorUniversity Hospital, BordeauxRan2017 to 2017Enrolled55ConditionsHuman Immunodeficiency VirusArmsblood sample
3 · Its place in the literature

Who cites it

237 citing papers in PubMed, 3 syntheses or guidelines pooled it, 387 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

177 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 3 countries.

David FurmanInstitute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, California, USA.
Junlei ChangDepartment of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California, USA.
Lydia LartigueINSERM U916 VINCO, Institut Bergonié, Bordeaux Cedex, France.
Christopher R BolenDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA.
François HaddadInstitute of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, USA.
Brice GaudilliereDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA.
Edward A GanioDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA.
Gabriela K FragiadakisDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA.
Matthew H SpitzerDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA.
Isabelle DouchetCIRID, UMR CNRS 5164, Université Bordeaux 2, Bordeaux Cedex, France.
Sophie DaburonCIRID, UMR CNRS 5164, Université Bordeaux 2, Bordeaux Cedex, France.
Jean-François MoreauCIRID, UMR CNRS 5164, Université Bordeaux 2, Bordeaux Cedex, France.
Garry P NolanDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA.
Patrick BlancoCIRID, UMR CNRS 5164, Université Bordeaux 2, Bordeaux Cedex, France.
Julie Déchanet-MervilleCIRID, UMR CNRS 5164, Université Bordeaux 2, Bordeaux Cedex, France.
Cornelia L DekkerDepartment of Pediatrics, Division of Infectious Diseases, Stanford University, Stanford, California, USA.
Vladimir JojicDepartment of Computer Science, University of North Carolina, Chapel Hill, North Carolina, USA.
Calvin J KuoDepartment of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California, USA.
Mark M DavisInstitute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, California, USA.
Benjamin FaustinCIRID, UMR CNRS 5164, Université Bordeaux 2, Bordeaux Cedex, France.
Stanford University · USCentre National de la Recherche Scientifique · FRHoward Hughes Medical Institute · USInstitut Bergonié · FRUniversité de Bordeaux · FRUniversity of North Carolina at Chapel Hill · US

Funding

Using a tonsil organoid system to probe conditions for the induction of protective antibody and T cell responses to influenza.U19AI057229 · NIAID · STANFORD UNIVERSITY · PI Mark Morris Davis · 2003 to 2026
$88.5M
Vaccination and infection: indicators of immunological health and responsivenessU19AI090019 · NIAID · STANFORD UNIVERSITY · PI DAVIS, MARK MORRIS · 2010 to 2015
$17.3M
Role of Myeloid Derived Suppressor Cells in the Immune Response to SurgeryK23GM111657 · NIGMS · STANFORD UNIVERSITY · PI GAUDILLIERE, BRICE · 2014 to 2017
$524k
NIAID NIH HHS U19 AI057229NIAID NIH HHS U19 AI090019NIGMS NIH HHS K23 GM111657
6 · The paper itself

Abstract

Low-grade, chronic inflammation has been associated with many diseases of aging, but the mechanisms responsible for producing this inflammation remain unclear. Inflammasomes can drive chronic inflammation in the context of an infectious disease or cellular stress, and they trigger the maturation of interleukin-1β (IL-1β). Here we find that the expression of specific inflammasome gene modules stratifies older individuals into two extremes: those with constitutive expression of IL-1β, nucleotide metabolism dysfunction, elevated oxidative stress, high rates of hypertension and arterial stiffness; and those without constitutive expression of IL-1β, who lack these characteristics. Adenine and N

Indexed as

AdenineAdultAgedAged, 80 and overAgingAnimalsBlood PlateletsBlood PressureCaffeineCalcium-Binding ProteinsCARD Signaling Adaptor ProteinsCarotid Intima-Media ThicknessCell LineCytidineCytokinesFemaleAdenineCaffeineCalcium-Binding ProteinsCARD Signaling Adaptor ProteinsCytidineCytokinesIL1B protein, humanIL1B protein, mouseIL1RN protein, humanInflammasomesInterleukin-1betaInterleukin 1 Receptor Antagonist ProteinIntracellular Signaling Peptides and ProteinsN-acetylcytidineNLRC4 protein, humanNLRC5 protein, humanNucleotidesPurinergic P1 Receptor AntagonistsTLR5 protein, humanTLR6 protein, humanTLR8 protein, humanToll-Like Receptor 5Toll-Like Receptor 6Toll-Like Receptor 8

Identifiers

PMID28092664
PMCPMC5320935
OpenAlexW2577141559

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.